94 related articles for article (PubMed ID: 21906450)
1. [Estrogen induced rat model of uterine leiomyoma].
Chen HG; Lan Z; Cui QC; Lang JH; Li B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):408-11. PubMed ID: 21906450
[TBL] [Abstract][Full Text] [Related]
2. Effects of gestrinone on uterine leiomyoma and expression of c-Src in a guinea pig model.
Zhu Y; Qiu XY; Wang L; Wu JH; Liu GM; He GL; Jiang XR; Sun ZY; Cao L
Acta Pharmacol Sin; 2007 May; 28(5):685-94. PubMed ID: 17439725
[TBL] [Abstract][Full Text] [Related]
3. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats.
Cook JD; Davis BJ; Goewey JA; Berry TD; Walker CL
Reprod Sci; 2007 Feb; 14(2):121-36. PubMed ID: 17636224
[TBL] [Abstract][Full Text] [Related]
4. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
Wu J; Cheng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
[TBL] [Abstract][Full Text] [Related]
5. [Experimental approach to leiomyomatosis peritonealis disseminata--progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced by estrogen (author's transl)].
Fujii S
Acta Obstet Gynaecol Jpn; 1981 May; 33(5):671-80. PubMed ID: 7234354
[TBL] [Abstract][Full Text] [Related]
6. The effect of cadmium on steroid hormones and their receptors in women with uterine myomas.
Nasiadek M; Swiatkowska E; Nowinska A; Krawczyk T; Wilczynski JR; Sapota A
Arch Environ Contam Toxicol; 2011 May; 60(4):734-41. PubMed ID: 20711721
[TBL] [Abstract][Full Text] [Related]
7. Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma.
Wang G; Ishikawa H; Sone K; Kobayashi T; Kim JJ; Kurita T; Shozu M
Fertil Steril; 2014 May; 101(5):1485-92. PubMed ID: 24636398
[TBL] [Abstract][Full Text] [Related]
8. Uterine leiomyomas: mechanisms of tumorigenesis.
Houston KD; Hunter DS; Hodges LC; Walker CL
Toxicol Pathol; 2001; 29(1):100-4. PubMed ID: 11215673
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium.
Hunter DS; Hodges LC; Vonier PM; Fuchs-Young R; Gottardis MM; Walker CL
Cancer Res; 1999 Jul; 59(13):3090-9. PubMed ID: 10397250
[TBL] [Abstract][Full Text] [Related]
11. [Effect of reinforcing qi for resolving masses method on expressions of MEK2 and p-ERK protein in estrogen induced uterine leiomyoma model guinea pigs' uterine tissue].
Wang N; Song ZM; Ruan SS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1408-11. PubMed ID: 24432690
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a rat model for uterine leiomyomas based on Western and traditional Chinese medicine theories.
Zhao H; Li Y; Xu Q; Peng F; Zhao J; Webb RC; Peng C; Yu C
Braz J Med Biol Res; 2018 Jul; 51(9):e7627. PubMed ID: 29972430
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic modality of induced uterine leiomyoma with shock waves in rats: The uterine blood flow, circulating ovarian hormones and histopathological findings.
Mamoon RS; Mawas AS; El Badry SM; Youssef AM; Ali MG; Aly MA; Abo El-Maaty AM
Reprod Biol; 2021 Jun; 21(2):100501. PubMed ID: 33773235
[TBL] [Abstract][Full Text] [Related]
16. Progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced by estrogen. Experimental approach to leiomyomatosis peritonealis disseminata.
Fujii S; Nakashima N; Okamura H; Takenaka A; Kanzaki H; Okuda Y; Morimoto K; Nishimura T
Am J Obstet Gynecol; 1981 Jan; 139(2):164-72. PubMed ID: 7457531
[TBL] [Abstract][Full Text] [Related]
17. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
18. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
Dwivedi A; Basu R; Chowdhury SR; Goyal N
Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
[TBL] [Abstract][Full Text] [Related]
19. Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids.
Hunter DS; Hodges LC; Eagon PK; Vonier PM; Fuchs-Young R; Bergerson JS; Walker CL
Environ Health Perspect; 2000 Oct; 108 Suppl 5():829-34. PubMed ID: 11035990
[TBL] [Abstract][Full Text] [Related]
20. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
Wang H; Jin J
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
